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Adolescents who exhibit exaggerated blood pressure (BP) reactivity to physical and mental challenges are at increased risk of
developing hypertension in adulthood. BP at rest and in response to challenges is higher in males than females, beginning in early
adolescence.CYP17A1 is one of the well-established gene loci of adult hypertension. Here, we investigated whether this gene locus is
associated with elevated BP at rest and in response to physical (active standing) andmental (math stress) challenges in adolescence.
We studied 496 male and 532 female adolescents (age 12–18 years) who were recruited from a genetic founder population. Our
results showed that the variant of CYP17A1 rs10786718 was associated with enhanced BP reactivity to the mental but not physical
challenge and in males but not females. In males, BP increase in response to math stress was higher in major versus minor allele
homozygotes by 7.6mmHg (𝑃 = 8.3 × 10−6). Resting BP was not associated with the CYP17A1 variant in either sex. These results
suggest that, in adolescent males but not females, CYP17A1 enhances BP reactivity to mental stress. Whether this effect contributes
to the higher prevalence of hypertension in males than females later in life remains to be determined.
1. Introduction
A growing body of evidence suggests that preclinical fea-
tures of hypertension emerge already during adolescence [1–
3], which is a period of human development when adult
blood pressure (BP) and body composition develop [4, 5].
Enhanced BP reactivity to a physical or mental stressor
in childhood and adolescence predicts adult hypertension
[6–8]. Marked sex differences exist in resting BP and BP
reactivity as well as in the prevalence of hypertension, with
all being higher in males than females during reproductive
years [6, 9–13].
Susceptibility to hypertension is determined by both
genetic and environmental factors.The estimated heritability
of resting BP and hypertension is around 50% [14]. Similarly,
the estimated heritability of BP response to math stress
is around 50% [15]. The underlying genetic architecture
involves multiple contributory genes. One of the well-
established gene loci of hypertension is CYP17A1 [16–22].
This gene encodes the enzyme cytochrome P-450c17 that
mediates steroid 17𝛼-hydroxylase and 17,20-lyase activities
(Figure 1). The first enzymatic activity is key in the steroido-
genic pathway that producesmineralocorticoids, which affect
sodium and water handling in the kidney, and glucocorti-
coids, which control the body response to stress [23, 24].
The second enzymatic activity is involved in the biosynthesis
of male and female sex hormones [24]. Thus, CYP17A1
may influence BP reactivity in a sex-specific manner. While
CYP17A1 is associated with resting BP and hypertension in
adults, whether the gene locus influences BP reactivity and
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Figure 1: Simplified pathway of steroid hormone biosynthesis and the role of CYP17A1. CYP17A1 encodes the enzyme cytochrome P-450c17𝛼
(CYP17) that catalyzes steroid 17𝛼-hydroxylase and 17,20-lyase activities and is hence essential for the synthesis of glucocorticoids (17𝛼-
hydroxylase activity) and sex steroids (17,20 lyase activity). Adapted fromMolina and Belldegrun, 2011 [28].
whether it plays a role in BP regulation already in adolescence
have not been studied.
The aim of this study was to investigate whether CYP17A1
is associated with BP at rest and in response to physical and
mental challenges during adolescence.This investigation was
carried out in a community-based sample of 1,028 adolescents
recruited from a genetic founder population of Quebec,
Canada [25–27].
2. Methods and Procedures
2.1. Study Population. White Caucasian adolescents (496
males, 532 females), aged 12 to 18 years, were recruited from
a genetic founder population living in the Saguenay-Lac St.
Jean region of Quebec, Canada, as part of the Saguenay Youth
Study [29]. This is a community-based cohort investigating
cardiometabolic and brain health in adolescence. Male and
female participants were recruited via high schools; detailed
recruitment and selection criteria are described elsewhere
[29]. The Saguenay Youth Study is family based, focusing on
collection of sib pairs.
The Saguenay-Lac St. Jean population is one of the largest
founder populations in North America [25–27], originating
fromFrench ancestors whomigrated to the region in the early
19th century. The population grew from 5,200 inhabitants
in 1852 to 285,000 at present, due to high intrinsic growth
and little emigration. Because of the founder effect, there
is a higher prevalence of certain recessive disorders in the
Saguenay-Lac St. Jean region compared with other popula-
tions [25], as well as limited allelic diversity among patients
with these disorders [26, 27].
The current study sample consists of 496 male and 532
female adolescents recruited and tested between November
2003 and February 2012. The prevalence of hypertension
(sitting SBP or DBP ≥95th age-, sex-, and height-specific
percentile) in this sample was 7.1% in males and 3.3% in
females, which is similar to that in the Canadian adolescent
population at large (Canadian Health Measures Survey)
[30]. Additional characteristics of the studied males and
females are provided in Table 1. Written consent from the
parents and assent from the adolescents were obtained
before the commencement of data collection. The research
ethics committees of the Chicoutimi Hospital and the
Hospital for Sick Children in Toronto approved the study
protocols.
2.2. Assessments. All adolescents underwent a 52-minute car-
diovascular protocol, conducted in the Chicoutimi Hospital
on Saturdays, commencing between 8:00 and 12:00 [29].
The protocol consisted of physical and mental challenges
(Figure 2). The physical challenges were changes in posture:
each participant was first supine for 10min, then standing for
10min, and finally sitting for 10min. The mental challenge
was a math-stress test, consisting of an explanation (<1min),
postexplanation waiting period (4min), math stress (2min),
and math-stress recovery (10min). The math stress was a
sequence of 46 simple arithmetic problems of increasing
difficulty (to ensure some failure in all participants) to be
solved out loud.
Throughout the protocol, a noninvasive hemodynamic
monitor, Finometer (FNS Finapres, Amsterdam, Nether-
lands), was used to record continuous finger blood flow. The
Finometer derives beat-by-beat brachial systolic BP (SBP)
and diastolic BP (DBP) by the reconstruction and level-
correction of the finger blood-flow waveform. This method
has been validated for tracking BP in adults and children over
the age of six years [31]. One-minute averages of these data
were calculated for the duration of the protocol and used to
compute twoBP reactivity parameters and two resting BPs for
each SBP and DBP (Figure 2). The BP reactivity parameters
were (1) BP reactivity to standing, which was a change in BP
from the last minute of supine to the first minute of standing,
and (2) BP reactivity to math stress, which was a change
in BP from the last minute of the prestress period to the
first minute of the math stress. The two resting BPs were (1)
poststanding resting BP, which was the average BP during the
last 5 minutes of the 10min sitting period during the posture
test, and (2) postmath resting BP, which was the average BP
during the last 5min of the 10-min period following the
math stress. Resting BPs were intended to mimic “clinic” BP,
defined by theCanadianHypertension Society as repeated BP
measurements taken after 5 minutes of rest while seated [32].
Sex-specific means and standard deviations of all initial and
resting BPs for SBP and DBP are presented in Table 1.
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Table 1: Basic characteristics and studied BP phenotypes.
Males Females Estimated difference (95% CI) 𝑃 value
(A) Basic characteristics∗
Age (years) 14.4 ± 1.8 14.6 ± 1.9 0.2 (−0.1–0.4) 0.15
Height (cm) 166.8 ± 10.7 159.6 ± 6.7 7.6 (6.7–8.6) <0.0001
Body weight (kg) 61.3 ± 16.9 56.0 ± 12.6 0.9 (−0.7–2.5) 0.29
BMI (kg/m2) 21.8 ± 4.6 21.9 ± 4.4 0.02 (−0.5–0.6) 0.94
(B) SBP, mmHg†
Prestanding 118.7 ± 12.8 120.1 ± 11.3 1.4 (−0.2–3.1) 0.09
Standing 129.6 ± 15.4 129.0 ± 13.5 0.6 (−1.4–2.6) 0.53
Reactivity to standing 11.1 ± 9.8 8.8 ± 9.2 2.3 (1.0–3.6) 0.0007
Premath stress 122.6 ± 14.2 119.7 ± 13.0 2.9 (1.0–4.8) 0.002
Math stress 140.4 ± 16.3 136.2 ± 14.6 4.3 (2.2–6.4) <0.0001
Reactivity to math stress 18.2 ± 10.6 16.7 ± 10.6 1.5 (0–3.0) 0.05
Poststanding restingc 123.2 ± 13.6 120.0 ± 11.8 3.1 (1.4–4.9) 0.0004
Postmath restingc 127.3 ± 13.1 124.8 ± 12.5 2.6 (0.8–4.3) 0.004
(C) DBP, mmHg†
Prestanding 70.3 ± 8.1 68.4 ± 7.4 1.9 (0.8–3.0) 0.0006
Standing 80.4 ± 11.1 78.8 ± 10.1 1.6 (0.1–3.1) 0.03
Reactivity to standing 10.4 ± 5.9 10.2 ± 5.8 0.2 (−0.7–1.0) 0.69
Premath stress 78.7 ± 9.6 76.1 ± 9.2 2.6 (1.3–3.9) 0.0001
Math stress 89.0 ± 11.4 86.6 ± 10.6 2.4 (0.8–3.9) 0.002
Reactivity to math stress 10.4 ± 5.8 10.6 ± 6.0 0.2 (−0.7–1.0) 0.67
Poststanding restingc 78.9 ± 9.6 76.1 ± 9.0 2.8 (1.5–4.1) <0.0001
Postmath restingc 81.9 ± 9.7 79.8 ± 8.9 2.2 (0.9–3.5) 0.001
∗Nonadjusted means ± standard deviations are shown. The differences between males and females are given, adjusted for age and, when appropriate, height.
†Means adjusted for age and height ± standard deviations are shown. The differences between males and females are given, adjusted for age and height.
cResting SBP/DBP is a 5-minute average of SBP/DBP measured while seated after 5 minutes at rest.
CI = confidence interval.
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Figure 2: Schematic diagram of the cardiovascular protocol.The cardiovascular protocol consisted of one physical challenge and one mental
challenge. The physical challenge was active posture test, which consisted of three periods during which the participant was first supine
(10 minutes), then standing (10 minutes), and finally sitting (10 minutes). The mental challenge was a math-stress test, which consisted of a
prestress (4min), explanation (∼1min), postexplanation waiting (4 minutes), math-stress (2 minutes), and math-stress recovery (10 minutes)
periods. Black squares indicate the initial and final BP values used to calculate BP reactivity to standing and math stress and the boxes show
5-minute averages of poststanding and postmath resting BPs.
2.3. Genotyping and Genotype Imputation. The study popu-
lation (𝑛 = 1, 028) was genotyped in two waves. The first
wave, involving 601 participants of the SYS, was genotyped
with the Illumina Human610-Quad BeadChip (Illumina, San
Diego, CA; 𝑛 = 582, 892 SNPs) at the Centre National de
Ge´notypage (Paris, France). The second wave, involving the
remaining 427 participants of the SYS, was genotyped with
the HumanOmniExpress BeadChip (Illumina, San Diego,
CA; 𝑛 = 729, 295 SNPs) at the Genome Analysis Centre
of Helmholtz Zentrum Mu¨nchen (Munich, Germany). In
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both subsamples, SNPs with call rate <95% and minor allele
frequency <0.01 and SNPs that were not in Hardy-Weinberg
equilibrium (𝑃 < 1 × 10−6) were excluded. After this
genotype quality control, 542,345 markers on the first SNP
chip and 644,283 markers on the second chip were available
for analysis.
Genotype imputation was used to equate the set of SNPs
of the adolescents genotyped on each platformand to increase
the SNP density. Haplotype phasing was performed with
SHAPEIT [33] using an overlapping subset of 313,653 post-
quality-control SNPs that were present on both genotyping
platforms and the 1,000 Genomes SNPs in European refer-
ence panel (Phase 1, Release 3). Imputation was conducted
on the phased data with IMPUTE2 [34]. Markers with low
imputation quality (information score < 0.5) or low minor
allele frequency (<0.01) were removed. After this imputation
quality control, a total of 1,392 typed and imputed SNPs
were available for a segment of human chromosome 10 that
covered the entire previously reported CYP17A1 locus of
adult SBP, DBP, and hypertension (∼400 kb from CYP17A1
to NT5C2 [17]) and its flanking sequences (90 kb upstream
of CYP17A1 and 147 kb downstream of NT5C2, Figure 3 and
Figure S4; see Supplementary Material available online at
http://dx.doi.org/10.1155/2015/734586).
2.4. Statistical Analyses. Genotype-phenotype association
analyses were conducted with Merlin (version 1.1.2) [35, 36]
under an additive model. They involved the above-selected
1,392 SNPs covering the previously reported CYP17A1 locus
[17] and the following SBP and DBP phenotypes: (1) BP reac-
tivity to math, (2) BP reactivity to standing, (3) poststanding
resting BP, and (4) postmath resting BP. With Merlin, a
simple regression model is fitted to each trait, and a variance
component approach is used to account for correlation
between observed phenotypes within sibships. Analyses were
done in males and females separately, with age, height,
and, when appropriate, initial BP included as covariates.
In supplementary analyses, body weight was added as an
additional covariate to control for potentially confounding
effects of obesity. BP values outside themean± three standard
deviations were excluded prior to these analyses (𝑛 = 974–
992 per variable). As we used a candidate-gene approach,
𝑃 < 0.05 was deemed significant for one test. However, since
we tested 4 blood pressure phenotypes in 2 sexes, our results
were considered significant at 𝑃 < 0.05/8 ≤ 6.3 × 10−3
whenBonferroni’s correction is applied. LocusZoom [37] was
used to view the results of the above-described genotype-
phenotype association analyses as plots showing both the
magnitude of association for each SNP (1,392 SNPswithin the
CYP17A1 locus) and the pairwise linkage disequilibrium (LD)
pattern with the most strongly associated SNP (Figure 3).
These plots were generated based on human genome hg19,
and the LD was calculated based on the 1,000 Genomes
Project (EUR reference panel, March 2012 version).
3. Results
The genotype-phenotype association analyses were carried
out while adjusting for age, height, and initial BP when
relevant. These analyses showed that, for both SBP and
DBP, the CYP17A1 locus was associated with enhanced BP
reactivity to the mental but not physical challenge, and
this was observed in males but not in females (Figure 3
and Table 2). The most significantly associated SNP was
rs10786718 (Figure 3). SBP increase in response to math
stress was higher in major versus minor allele homozygotes
by 7.6mmHg (𝑃 = 8.3 × 10−6) in males. Likewise, DBP
increase in response tomath stress was higher inmajor versus
minor allele homozygotes by 4.8mmHg (𝑃 = 1.1 × 10−5)
in males (Figure S1). Neither poststanding nor postmath
resting BPs were associated with the CYP17A1 locus in
either sex (Figure 3 and Table 2). All these results remained
virtually unchanged when additionally adjusted for body
weight (Figures S2 and S3), indicating that theCYP17A1 locus
impacts BP independently of obesity. Similar to the previous
studies, the CYP17A1 locus showed a long-range LD pattern,
spreading over a region of ∼400 kb [17]. In the present
study, however, this locus contained a subregion of highly
correlated SNPs that demonstrated a stronger association
with the BP phenotype and was closer to CYP17A1 (Figure 3);
this observation provides further support for the possibility
that CYP17A1may be the causal gene within this BP locus.
4. Discussion
The results of the current study show that a well-established
gene locus of hypertension in adults [16–22], CYP17A1,
may play a role in increasing BP reactivity to stress during
adolescence. This effect, however, may be sex-specific and
limited to mental stressors.
CYP17A1 has been identified as a gene locus of hyperten-
sion and resting bloodpressure in several large-scale genome-
wide and replication studies of adult European and Asian
populations [16–20]. It encodes a key enzyme in the steroido-
genic pathway that may influence BP through its effects
on the production of mineralocorticoids, glucocorticoids,
and sex hormones. The enzyme has both 17𝛼-hydroxylase
and 17,20-lyase activities that contribute to steroidogenesis
in the adrenal gland and sex gonads [24]. During that
process, pregnenolone derived from cholesterol is processed
to (a) mineralocorticoids in the adrenal zona glomerulosa
(neither enzyme activity present), (b) glucocorticoids in the
adrenal zona fasciculata (17𝛼-hydroxylase activity present),
or (c) sex steroids in the adrenal zona reticularis and gonads
(both enzyme activities present) [24]. Each of these steroid
hormones plays a role in the regulation of BP. (a) Mineralo-
corticoids (e.g., aldosterone) can increase BP by augmenting
renal sodium and water reabsorption and thus circulating
blood volume [23]. (b) Glucocorticoids (e.g., cortisol) can
increase BP by enhancing the vasoconstrictive effects of
catecholamines, as well as by having some mineralocorticoid
activity described above [23]. (c) Sex steroids impact BP
mostly indirectly, via their influences on the autonomic and
renin-angiotensin-aldosterone systems, endothelial function,
and oxidative stress; in general, androgens are considered
to be BP-increasing, while estrogens are thought to be BP-
decreasing [12, 38]. Importantly, some of the above effects of
steroid hormones underlie slower BP responses (e.g., blood
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volume regulation) whereas other effects mediate faster BP
responses (e.g., the enhancement of catecholamine-driven
vasoconstriction). The latter ones are more likely to be
relevant to the present study of acute BP reactivity.
The regulation of BP reactivity to mental stress involves
the coordinated action of the hypothalamic-pituitary-adrenal
(HPA) and autonomic nervous systems, whereas the regu-
lation of BP reactivity to simple standing up engages only
the autonomic system (baroreflex) [39, 40]. Our results show
that the CYP17A1 locus is associated with BP reactivity to
mental stress but not to active standing up. This observation
is consistent with mental stress (but not active standing
up) involving the activation of the HPA axis and CYP17A1
regulating the production of its final effector, cortisol [23].
Further, our results suggest that CYP17A1 is involved in
the regulation of BP reactivity to mental stress mainly in
males. SBP increase in response to math stress was higher in
major versus minor allele homozygotes by 6.3mmHg (𝑃 =
8.3 × 10
−6) but only by 1.6mmHg (𝑃 = 0.52) in females.
Although CYP17A1 increases the production of both male
and female sex hormones, androgens are expected to enhance
BP reactivity, whereas estrogens are predicted to suppress
BP reactivity [12, 38]. As such, sex hormones, through their
opposing modulatory effects, may lead to the development
of the observed sex dimorphism in the genotype-phenotype
association. Taken together, CYP17A1 may contribute to the
regulation of BP reactivity tomental stress through its parallel
effects on the production of cortisol and sex hormones.
Finally, our study did not observe significant association
between CYP17A1 and resting BP in either males or females.
It is likely that, at this stage, the effect of the gene is
detectable on BP reactivity but not yet on resting BP. Previous
research suggests that enhanced BP reactivity increases risk
for future hypertension [6–8]. Chronically exaggerated BP
responses increase repeatedly pressure load on the vessels,
heart, and kidneys, leading to their structural and functional
adaptations, which in turn may increase resting BP and
promote the development of hypertension over time. Given
that CYP17A1 may enhance BP reactivity to mental stress,
it may be an early genetic marker of hypertension risk.
Substantial overlap exists between genes influencing clinic
BP and BP measured in an experimental setting. It has been
estimated that up to 81% of the heritability of clinic SBP
and 71% of the heritability of clinic DBP were attributed to
genes that also influenced stress BP during a video game
challenge and social stress interview [41]. Although this locus
is a well-established locus of hypertension in adults [16–
22], further studies in adolescents and young adults are
needed to elucidate its potential age and sex dependence and
phenotypic transition from enhanced reactivity to elevated
resting blood pressure.
Our results remained virtually unchangedwhen adjusted,
or not adjusted, for body weight (Figures S2 and S3), indi-
cating that the CYP17A1 locus impacts BP independently
of obesity. As such, the locus may be relevant obesity-
dissociated hypertension [42]. Although obesity is a leading
risk factor of hypertension, obesity and hypertension do not
have 1 : 1 correspondence; only about 50%of obese individuals
are hypertensive and about 30% of hypertensive individuals
are not obese [43].
The CYP17A1 locus was discovered as a relatively wide
locus, including several genes [17]. It was named theCYP17A1
locus, as CYP17A1was considered the best physiological can-
didate within the association locus. Nevertheless, other genes
within the identified locus cannot be entirely excluded. The
two genes closest to CYP17A1 are C10orf32, which encodes
“chromosome 10 open reading frame 32” (a protein of
unknown function), and AS3MT, which encodes an enzyme
that catalyzes the transfer of amethyl group from S-adenosyl-
L-methionine to trivalent arsenical and may play a role in
arsenicmetabolism [44]. However, the role of these two genes
in blood pressure regulation is not clear.
In conclusion, our results suggest that, in adolescent
males but not females, CYP17A1 enhances BP reactivity to
mental stress. Whether this effect contributes to the higher
prevalence of hypertension in males than females later in life
remains to be determined.
Perspectives
Adolescence is a period of human development when adult
physiology develops and initial stages of cardiovascular dis-
orders, including hypertension,may emerge. Our hope is that
it is also a period when disease trajectories can still be altered
and full-blown diseases (such as hypertension) prevented.
Early vulnerability genes may represent useful tools in this
effort.
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